Objectives: To evaluate single disease quality management and cost control status in Jilin province.
目的：了解吉林省病种质量管理与费用控制现状。
Results: gaps existed between Jilin province and national standard in single disease quality management and cost control. The ratio of drug income to total medical cost was too high.
结果：吉林省病种质量指标与部颁标准有一定差距，医疗费用中药品费用过高。
Conclusion Single disease quality management can greatly standardize the treatment behavior and improve the prognosis of CIS patients by controlling the quality of treatment procedure.
结论缺血性脑卒中单病种质量管理通过对诊疗过程的质量控制，规范了诊疗行为，改善了新发缺血性脑卒中患者的预后。
应用推荐